Instil Bio, Inc.
TIL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $137,415 | $113,407 | $124,579 |
| - Cash | $5,801 | $7,688 | $15,366 | $8,805 |
| + Debt | $84,613 | $6 | $86,669 | $86,886 |
| Enterprise Value | – | $129,733 | $184,710 | $202,660 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$12 | $0 | $0 | -$741 |
| % Margin | – | – | – | – |
| EBITDA | -$11,750 | -$19,800 | -$26,816 | -$8,564 |
| % Margin | – | – | – | – |
| Net Income | -$13,587 | -$21,394 | -$28,200 | -$11,895 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.01 | -3.24 | -4.32 | -1.82 |
| % Growth | 38% | 25% | -137.4% | – |
| Operating Cash Flow | -$10,557 | -$14,791 | -$4,195 | -$10,559 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$10,557 | -$14,791 | -$4,195 | -$10,559 |